Bristol-Myers Squibb Company BMY
Price alert —
Sign in to get a one-time email the moment BMY crosses your price. Free accounts included.
Sign in / create a free accountBristol-Myers Squibb Company is a healthcare company listed in the US.
BMY last traded at $60.74, up 0.4% on the day; that's in the upper part of its 52-week range ($53.44–$62.89). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
On the latest daily bar, momentum sits mid-range (RSI 61), the trend is quiet (ADX 17), and volume is about normal (0.9×). On the business side, revenue is growing 3% year over year and the business keeps about 20 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
Our cash-flow model pegs fair value near $55.95 (fair range $56–$96); today's price sits 11% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ Positive retained earnings
- ✓ Gross margin 72% (pricing power)
- ⚠ Debt exceeds cash
- ⚠ Quick ratio 0.86 (fragile)
- ⚠ Debt/equity 3.87 (fragile)
- ⚠ Receivables growing faster than revenue
Price implies ~4% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
BMY is a $118.0 billion company, priced at 17× last year's earnings.